Sanofi India Limited (NSE:SANOFI)

Market Cap	116.92B
Revenue (ttm)	28.23B
Net Income (ttm)	4.60B
Shares Out	n/a
EPS (ttm)	199.60
PE Ratio	25.43
Forward PE	n/a
Dividend	4,837.00 (95.32%)
Ex-Dividend Date	n/a

Volume	23,759
Average Volume	14,034
Open	5,140.00
Previous Close	5,168.60
Day's Range	5,055.00 - 5,168.60
52-Week Range	5,055.00 - 10,525.00
Beta	0.28
RSI	31.53
Earnings Date	Feb 21, 2025

About Sanofi India

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through indepe...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1956
• Employees: 2,174
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SANOFI

Financial Performance

In 2023, Sanofi India's revenue was 28.51 billion, an increase of 2.92% compared to the previous year's 27.70 billion. Earnings were 6.03 billion, a decrease of -2.85%.